MerLion Pharmaceuticals Pte Ltd

The global response to the antimicrobial resistance crisis has seen success using incentives to attract new specialty companies into the scientifically difficult and commercially unattractive infectio

One way of describing the Nov. 5 meeting of FDA’s Antimicrobial Drugs and Drug Safety & Risk Management Advisory Committees focused on a long-standing safety concern with a very widely used class of d

MerLion Pharmaceuticals Pte. Ltd. is looking to raise money, engage a partner or both to progress the fluoroquinolone antibiotic finafloxacin into Phase III clinical trials, following positive Phase

Scrip caught up with several biopharma executives on Sept. 18 during the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and International Congress of Chemotherapy and Infect